cerrar
Tagged with R&D

Clinical Trials in Korea: Top Facts
An outline of the geographical distribution of clinical trial sites in South Korea. 184 medical institutions were designated by the Korean government…

Spain’s Clinical Trial Landscape
Within the past decade, Spain has developed into a top player in the European clinical trial network. The pharmaceutical industry has been increasing…

Real-World Evidence – A Game Changer for Pharma
Nawal Roy is founder and CEO of Holmusk, a company dedicated to building one of the world’s largest real-world evidence platforms for neurosciences.…

Clinical Research in Malaysia: Top Facts
A map showing 18 of the active clinical trials sites in Malaysia in 2017. The sites are spread across the entire nation and cover a variety of…

Showcasing Korea’s clinical research potential: The Fourth…
From Wednesday 31st October to Friday 2nd November, Seoul hosted the KoNECT-MFDS International conference, promoting South Korea’s clinical research…

Korea: An Up and Coming Pharma Industry
Korea is fast becoming a big player in the pharmaceutical industry, especially within the biotech arena. With 4% of the total pipelines in the world,…

Maria Fernanda Prado – Managing Director, Janssen Turkey
Maria Fernanda Prado, managing director of Janssen Turkey, elaborates on the unique dynamics at play in Turkey; an important emerging market. Prado…

Korea: Hanmi Gets FDA Orphan Drug Approval for Leukaemia…
Korean Pharma company, Hanmi has won orphan drug status this week from the US Food and Drug Administration (FDA) for HM43239, a drug for the treatment…

Exclusive interview with David Meek, global CEO of Ipsen
Ipsen CEO David Meek provides a fascinating look into the French pharmaceutical ecosystem, Ipsen’s bold global expansion plans, its R&D…

David Meek – CEO, Ipsen
Ipsen global CEO David Meek provides a fascinating look into the French pharmaceutical ecosystem, Ipsen’s bold global expansion plans, its R&D…

Francesc Posas – Director, IRB Barcelona, Spain
Francesc Posas, the newly appointed director of the Institute for Research in Biomedicine (IRB Barcelona), explains the evolving role of the institute…

Frédéric Revah – CEO, Genethon; President, YposKesi,…
Genethon, a laboratory created by the patient organization AFM-Telethon, is one of the world’s leaders in the development of biotherapies for rare…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here